2023 Annual Meeting | N1 - Neuroscience in the Clinic: Predicting, Evaluating, and Modifying Risk of Delirium

Date Saturday 04/22/23

Time 12:15 PM - 02:15 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Eyal Y. Kimchi, MD, PhD, Sara LaHue, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants should be able to comprehend risk factors for delirium, understand the role of ancillary testing in delirium risk stratification, analyze delirium pathophysiology in clinical and research contexts, and apply an understanding of delirium pathophysiology to prevention and treatment of delirium.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
12:15 PM - 12:20 PM EST	Introduction	Introduction Eyal Y. Kimchi, MD, PhD
12:20 PM - 12:45 PM EST	Speaker	Electrophysiological Insights into Delirium and Encephalopathy M. B. Westover, MD, PhD
12:45 PM - 01:10 PM EST	Speaker	What Neuroimaging Reveals about Delirium Pathophysiology Tamara G. Fong, MD, PhD
01:10 PM - 01:35 PM EST	Speaker	Cerebrospinal Fluid Biomarkers of Delirium and Tissue Integrity Sara LaHue, MD
01:35 PM - 01:45 PM EST	Abstract	001 - Localizing Delirium through Automated Lesion Segmentation and Neural Network Mapping John Y. Rhee, MD, MPH
01:45 PM - 01:55 PM EST	Abstract	002 - The Use of Intraoperative Neuromonitoring to Predict Post-Operative Delirium in Patients Undergoing Cardiac Surgery: A Retrospective Study Vamsi Krishna Gorijala, MBBS
01:55 PM - 02:10 PM EST	Discussion	Panel Discussion Eyal Y. Kimchi, MD, PhD, Sara LaHue, MD, Tamara G. Fong, MD, PhD, M. B. Westover, MD, PhD
02:10 PM - 02:15 PM EST	Closing Remarks	Closing Remarks Eyal Y. Kimchi, MD, PhD

Faculty Disclosures
Eyal Y. Kimchi, MD, PhD	The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH.
Sara LaHue, MD	The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . Dr. LaHue has received publishing royalties from a publication relating to health care.
Tamara G. Fong, MD, PhD	Dr. Fong has nothing to disclose.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
	No disclosure on file
Anna K. Bonkhoff, MD	Dr. Bonkhoff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroImage Clinical (Elsevier).
Kathirvel Subramaniam	No disclosure on file
Natalia S. Rost, MD, MPH, FAHA, FAAN	Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
John Y. Rhee, MD, MPH	Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. Dr. Rhee has received publishing royalties from a publication relating to health care. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Abigail Adams Institute.
Sophia Ryan, MD	Dr. Ryan has nothing to disclose.
Senthilkumar Sadhasivam	No disclosure on file
Vamsi Krishna Gorijala, MBBS	Dr. Gorijala has nothing to disclose.
Michael D. Fox, MD, PhD	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Michael Ferguson	No disclosure on file
Parthasarathy Thirumala, MD, FAAN	The institution of Dr. Thirumala has received research support from University of Pittsburgh.
Abdullah Al Qudah	No disclosure on file